Showing results (61-70 of 74) with videos related to
Sort By:
Pageof 8
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 25, 2000
Evaluation of serum alkaline DNase activity in treatment monitoring of head and neck cancer patientsP S Patel, B P Patel, R M Rawal, et al.Head & Neck|April 20, 1999
Evaluation of glycoprotein constituents in head and neck cancer patients undergoing radiotherapyR M Rawal, P S Patel, B P Patel, et al.Oral Oncology|March 1, 2000
Evaluation of telomerase activation in head and neck cancerM M Patel, D D Patel, L J Parekh, et al.Contraception|May 1, 1987
ICMR task force study on hormonal contraception. Transfer of levonorgestrel (LNG) administered through different drug delivery systems from the maternal circulation into the newborn infant's circulation via breast milkZ K Shikary, S S Betrabet, Z M Patel, et al.Vaccine: X|July 28, 2022
Antibody persistence following administration of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines at 12-24 months of age and safety and immunogenicity of a booster dose of DTwP-IPV-HB-PRP∼T in healthy infants in IndiaS Mangarule, S Palkar, M Mitra, et al.Critical Care Medicine|June 2, 2000
Desmethyl tirilazad improves neurologic function after hypoxic ischemic brain injury in pigletsY Feng, M H LeBlanc, E B LeBlanc, et al.Endocrinology|July 3, 2004
Impaired glucose-stimulated insulin secretion, enhanced intraperitoneal insulin tolerance, and increased beta-cell mass in mice lacking the p110gamma isoform of phosphoinositide 3-kinaseP E MacDonald, J W Joseph, D Yau, et al.Neoplasma|October 17, 2002
Serum glutathione-S-transferase and glutathione reductase activity in head and neck cancer patientsB P Patel, G N Raval, R M Rawal, et al.Vaccine: X|April 25, 2022
Safety and immunogenicity of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines in healthy infants in IndiaS Mangarule, S Palkar, M Mitra, et al.Journal of Medicinal Chemistry|May 14, 1993
Interphenylene 7-oxabicyclo[2.2.1]heptane oxazoles. Highly potent, selective, and long-acting thromboxane A2 receptor antagonistsR N Misra, B R Brown, P M Sher, et al.Pageof 8